Evidence map›Paper›PMID 38528140›Full record

ArticleEMBO molecular medicine2024

Gene therapy for deafness: are we there now?

Tobias Moser, Han Chen, Kathrin Kusch, Rüdiger Behr, Barbara Vona

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. A Novel Pathogenic Haplotype inBalkan medical journal · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Rapid cochlear gene therapy in adult deaf mice:Molecular therapy. Methods & clinical development · 2025
    Article
  7. IsMedComm · 2025
    Article
  8. Article
  9. Toward elucidating the mechanism of cochlear stimulation by infrared light.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Advancing precision ear medicine: leveraging animal models for disease insights and therapeutic innovations.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tobias MoserInstitute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37099, Göttingen, Germany. tmoser@gwdg.de.ORCID 0000-0001-7145-0533
Han ChenInstitute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37099, Göttingen, Germany.ORCID 0009-0003-1357-5161
Kathrin KuschInstitute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37099, Göttingen, Germany.
Rüdiger BehrPlatform Degenerative Diseases, German Primate Center, Göttingen, Germany.ORCID 0000-0001-8816-6619
Barbara VonaInstitute for Auditory Neuroscience and InnerEarLab, University Medical Center Göttingen, 37099, Göttingen, Germany.ORCID 0000-0002-6719-3447

Funding

Deutsche Forschungsgemeinschaft (DFG) EXC 2067/1- 390729940Deutsche Forschungsgemeinschaft (DFG) MO896/5Deutsche Forschungsgemeinschaft (DFG) VO 2138/7-1Fondation Pour l'Audition (FPA) FPA RD-2020-10Max-Planck-Gesellschaft (MPG) Max-Planck-Fellowship
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DeafnessGenetic TherapyHumans

Identifiers

PMID38528140
PMCPMC11018804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.